Janas, Maja M.
Alnylam Pharmaceuticals (United States)
2 papers on CoChatORCID 0000-0003-2110-539X
Most cited papers
- Verified
Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity
Janas, M. M., Schlegel, M. K., Harbison, C. E., Yilmaz, V. O., Jiang, Y., Parmar, R., Zlatev, I., Castoreno, A., Xu, H., Shulga-Morskaya, S., et al. (2018) · Nature Communications
RNA Interference and Gene DeliveryDrug-Induced Hepatotoxicity and Protection
Cited by 279
- Verified
Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
Brown, K. M., Nair, J. K., Janas, M. M., Anglero-Rodriguez, Y. I., Dang, L. T. H., Peng, H., Theile, C. S., Castellanos-Rizaldos, E., Brown, C., Foster, D., et al. (2022) · Nature Biotechnology
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 258
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free